Cargando…
Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
The use of antiretrovirals (ARVs) as oral, topical, or long-acting pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for HIV prevention. Clinical trials testing Truvada(®) [tenofovir disoproxil fumarate (TDF)/tenofovir (TFV) and emtricitabine (FTC)] as oral or topical PrEP in Afric...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557974/ https://www.ncbi.nlm.nih.gov/pubmed/36246609 http://dx.doi.org/10.3389/fgene.2022.940661 |